http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110420228-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24ae3ff27b64d8d6516ec5127c1ac829 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
filingDate | 2019-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d417dacc13a7606d36602fec7947f671 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01f74a067efd009458a101b33844e6ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e04fd8b6810e0b61057be39bccf66d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14871b08182ee466ebf87b8ee47c5761 |
publicationDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110420228-A |
titleOfInvention | Application of Bacteroides fragilis YCH46 in the preparation of drugs for the treatment or auxiliary treatment of hypertension |
abstract | The invention relates to the application of Bacteroides fragilis YCH46 in the preparation of medicines for treating or assisting the treatment of hypertension. The present invention discovers for the first time the key role of Bacteroides fragilis YCH46 in the human intestinal tract in hypertension, and the Bacteroides fragilis YCH46 can inhibit the synthesis of intestinal corticosterone and effectively lower blood pressure. In addition, because Bacteroides fragilis YCH46 itself is a microorganism that normally exists in the intestinal tract, it will not have side effects on the body and has incomparable advantages compared to other new drugs. Utilizing the key role of Bacteroides fragilis YCH46 in hypertensive diseases in the present invention, it can be prepared into medicines, pharmaceutical compositions, food, health products or food additives, which can be used to treat essential hypertension and salt-sensitive hypertension. It has important application value in hypertensive diseases. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112587552-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112587552-A |
priorityDate | 2019-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.